The study of genetically modified mice has greatly expanded our understanding of kidney development and pathophysiology. The UTSW O'Brien Center Animal Models Core will continue to provide cutting edge technology to investigators wishing to generate mouse models for the study of kidney development and/or function. The core will serve three major purposes. One is to provide the necessary reagents and expertise to mouse geneticists who do not normally study the kidney to facilitate and encourage their move into this field. The second is to encourage non-mouse geneticists, especially clinical investigators, to venture into the mouse system and to ease this transition. The third is to provide tools to mouse geneticists who do study the kidney to assist in their studies. This will be accomplished in several ways. First, the core will generate and distribute several kidney specific Cre recombinase and tetracycline inducible activator and repressor lines to be crossed to co-investigator provided floxed or tet responder lines. Second, core personnel will assist in the generation of additional transgenic mice, knockout/in mice and cell lines as required by co-investigators. Finally, core personnel will perform and train investigators in the use of various models of organ injury/repair and ex vivo culture. As mentioned, the ultimate purpose of this core is to facilitate research on kidney development and pathophysiology.

Public Health Relevance

Due to its physiology, size, reproductive cycle, lifespan and the fact that it is an intensively studied model sytstem, the mouse represents the most appropriate experimental system to model human kidney development and pathobiology. As evidenced by its extensive usage, the animal core continues to provide cutting edge services to a broad scientific community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK079328-06
Application #
8433614
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (M1))
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-05-31
Support Year
6
Fiscal Year
2012
Total Cost
$216,746
Indirect Cost
$80,392
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Ramalingam, Harini; Fessler, Alicia R; Das, Amrita et al. (2018) Disparate levels of beta-catenin activity determine nephron progenitor cell fate. Dev Biol 440:13-21
Raman, Archana; Parnell, Stephen C; Zhang, Yan et al. (2018) Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease. Am J Physiol Renal Physiol :
Chen, Gaozhi; Liu, Yang; Goetz, Regina et al. (2018) ?-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature 553:461-466
Pastor-Arroyo, Eva-Maria; Gehring, Nicole; Krudewig, Christiane et al. (2018) The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int 94:49-59
Ferrè, Silvia; Igarashi, Peter (2018) New insights into the role of HNF-1? in kidney (patho)physiology. Pediatr Nephrol :
Ferrè, Silvia; Li, Xilong; Adams-Huet, Beverley et al. (2018) Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study. Nephrol Dial Transplant 33:1389-1396
Micanovic, Radmila; Khan, Shehnaz; Janosevic, Danielle et al. (2018) Tamm-Horsfall Protein Regulates Mononuclear Phagocytes in the Kidney. J Am Soc Nephrol 29:841-856
Hato, Takashi; Zollman, Amy; Plotkin, Zoya et al. (2018) Endotoxin Preconditioning Reprograms S1 Tubules and Macrophages to Protect the Kidney. J Am Soc Nephrol 29:104-117
Gazdhar, Amiq; Ravikumar, Priya; Pastor, Johanne et al. (2018) Alpha-Klotho Enrichment in Induced Pluripotent Stem Cell Secretome Contributes to Antioxidative Protection in Acute Lung Injury. Stem Cells 36:616-625
Baum, Michel (2018) Progression of chronic kidney disease in children. Curr Opin Pediatr 30:216-219

Showing the most recent 10 out of 260 publications